MedTrace Logo

Effects of Including Sprints During Low-intensity Cycling Exercises on Performance and Muscle/Blood Characteristics

NCT04640883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-11-23

No results posted yet for this study

Summary

To investigate the effects of Including 30-s sprints during low-intensity cycling exercises during a training camp on performance and muscle/blood characterisitcs in elite cyclists

Conditions

  • Healthy
  • Cyclists

Interventions

BEHAVIORAL

Inclusion of sprints during low-intensity cycling during a 14-day training camp (high training load)

Inclusion of 12x30-s maximal sprints during five low-intensity cycling sessions with long duration (\>fours hours per session). Five sessions will be performed as low-intensity cycling-only (Controll sessions, distance matched). All other sessions will be performed as low-intensity sessions and adjusted according to each participants training load goal to reach an increase of \~50% in load compared to habitual training.

BEHAVIORAL

Low-intensity cycling during a 14-day training camp (high training load)

Five low-intensity cycling sessions (\>four hours per session), distance-matched to sprint group.

BEHAVIORAL

Recovery for 10 days (low training load)

Habitual low-intensity cycling (\>0.5-2 hours per session)

Sponsors & Collaborators

  • Inland Norway University of Applied Sciences

    lead OTHER

Principal Investigators

  • Anne S Lofthus · Research Administrator

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-23
Primary Completion
2017-12-23
Completion
2017-12-23

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04640883 on ClinicalTrials.gov